Suppr超能文献

姜黄素衍生物MTH-3调节棕榈酸酯诱导的小鼠成肌细胞CC细胞中的胰岛素抵抗。

Curcumin Derivative MTH-3 Regulates Palmitate-induced Insulin Resistance in Mouse Myoblast CC Cells.

作者信息

Chiu Yu-Jen, Lo Yu-Hsiang, Yang Jai-Sing, Kuo Sheng-Chu, Tsai Shih-Chang

机构信息

Division of Plastic and Reconstructive Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.

Department of Surgery, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.

出版信息

In Vivo. 2021 Nov-Dec;35(6):3181-3191. doi: 10.21873/invivo.12613.

Abstract

BACKGROUND/AIM: At present, there are no effective drugs for the treatment of insulin resistance. MTH-3, a curcumin derivative, exerts potent anti-cancer effects. The aim of the present study was to explore whether MTH-3 is capable of regulating palmitic acid (PA)-induced insulin resistance in CC cells.

MATERIALS AND METHODS

Cell viability was examined using the MTT assay. CC cells were treated with PA and evaluated for the production of oil droplets using an Oil Red O assay. Glucose uptake was analysed by the 2-NBDG assay.

RESULTS

Treatment of cells with up to 500 μM PA for 24 h or with 5 or 10 μM MTH-3 had no effect on cell viability. PA induced production of oil droplets in CC cells. After adding MTH-3, the quantity of oil droplets decreased significantly and glucose uptake recovered.

CONCLUSION

MTH-3 may become an efficient drug for the treatment of insulin resistance and associated diseases.

摘要

背景/目的:目前,尚无治疗胰岛素抵抗的有效药物。姜黄素衍生物MTH-3具有强大的抗癌作用。本研究的目的是探讨MTH-3是否能够调节棕榈酸(PA)诱导的CC细胞胰岛素抵抗。

材料与方法

采用MTT法检测细胞活力。用PA处理CC细胞,并使用油红O法评估油滴的产生。通过2-NBDG法分析葡萄糖摄取。

结果

用高达500μM的PA处理细胞24小时或用5或10μM的MTH-3处理对细胞活力没有影响。PA诱导CC细胞中油滴的产生。添加MTH-3后,油滴数量显著减少,葡萄糖摄取恢复。

结论

MTH-3可能成为治疗胰岛素抵抗及相关疾病的有效药物。

相似文献

本文引用的文献

2
FFAR4: A New Player in Cardiometabolic Disease?FFAR4:心脏代谢疾病的新靶点?
Endocrinology. 2021 Aug 1;162(8). doi: 10.1210/endocr/bqab111.
4
Epidemiology and determinants of obesity in China.中国肥胖症的流行病学及决定因素。
Lancet Diabetes Endocrinol. 2021 Jun;9(6):373-392. doi: 10.1016/S2213-8587(21)00045-0.
10
NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2.非酒精性脂肪性肝病、胰岛素抵抗和 2 型糖尿病。
Can J Gastroenterol Hepatol. 2021 Feb 17;2021:6613827. doi: 10.1155/2021/6613827. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验